en.wikipedia.org/wiki/Abdullahi_v._Pfizer,_Inc.

The Kano trovafloxacin trial litigation arose out of a clinical trial conducted by the .... ever been treated with Trovan, and then only after all other antibiotics failed.

law.justia.com/cases/federal/district-courts/illinois/ilndce/1:2017cv06730/344210/83

Aug 3, 2018 ... Al Haj et al v. Pfizer Inc, No. 1:2017cv06730 - Document 83 (N.D. Ill. 2018) case opinion from the Northern District of Illinois US Federal District ...

law.justia.com/cases/federal/appellate-courts/ca7/17-2056/17-2056-2018-01-19.html

Jan 19, 2018 ... In Wyeth v. Levine, the Supreme Court held that claims against a manufacturer of a brand-name prescription drug for failure to warn adequately ...

www.justice.gov/atr/antitrust-case-filings-alpha

Dec 20, 2018 ... U.S. v. A&L Mayer Associates, Inc.; A&L Mayer, Inc.; and Fibras Saltillo, S.A. de .... v. American Society of Composers, Authors and Publishers, et al. ..... Cassady, Fuller & Marsh; Dowling & Charmichael; Pittman, ...... Pfizer, Inc.

www.chamberlitigation.com/sites/default/files/cases/files/18181818/Petition%20for%20Permission%20to%20Appeal%20--%20Adamyan%20v.%20Pfizer%2C%20Inc.%20%28Ninth%20Circuit%29.pdf

ALIDA ADAMYAN, et al.,*. Plaintiffs-Respondents, v. PFIZER INC.,. Defendant- Petitioner. Petition for Permission to Appeal From United States District Court,.

www.ditommasolaw.com/crain-s-chicago-business.html

Jeff Kindler, Pfizer Inc.'s general counsel, New York ... Boim v. Quranic Literacy Institute et al. Hamas' domestic supporters must pay $156 million to slain teen's ...

www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM583915.pdf

Nov 7, 2017 ... Manufacturer: SA4Ag is manufactured by Pfizer Inc. 2. ..... Source: (a) ABCs, 20148 and See et al, 20159; (b) Includes 37 CDC-selected NHSN ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4110852

Opioids play an important role in the treatment of chronic pain [Trescot et al. ... a good safety profile and reduction in drug likability [Pfizer Inc., 2009; Stauffer et al. .... mm versus 1.3) and drug-liking scores (38.9 versus 81.4 versus 0.0 mm) all were .... Butler S., Cassidy T., Chilcoat H., Black R., Landau C., Budman S., et al.

www.cnbc.com/video/2018/11/08/analyst-on-how-new-house-leadership-will-affect-financials.html

Analyst on how new House leadership will affect financials. 6:33 AM ET Thu, 8 Nov 2018. Gerard Cassidy, RBC Capital Markets banking analyst, discusses the  ...